2,3-dinor-thromboxane b2 and Arterial Obstructive Diseases

2,3-dinor-thromboxane b2 has been researched along with Arterial Obstructive Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frölich, JC; Gutzki, FM; Kreutzer, FJ; Nowak, V; Stichtenoth, DO; Tsikas, D	1

Trials

1 trial(s) available for 2,3-dinor-thromboxane b2 and Arterial Obstructive Diseases

Article	Year
Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease. Prostaglandins, leukotrienes, and essential fatty acids, 2001, Volume: 65, Issue:4 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arterial Occlusive Diseases; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Gas Chromatography-Mass Spectrometry; Humans; Infusions, Intravenous; Kinetics; Male; Middle Aged; Nitrates; Oxygen; Thromboxane B2	2001

Article

Year

Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.

Prostaglandins, leukotrienes, and essential fatty acids, 2001, Volume: 65, Issue:4

Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arterial Occlusive Diseases; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Gas Chromatography-Mass Spectrometry; Humans; Infusions, Intravenous; Kinetics; Male; Middle Aged; Nitrates; Oxygen; Thromboxane B2

2001